Yet despite these benefits, some patients taking GLP-1 medications report serious gastrointestinal issues (such as gastroparesis and bowel obstruction) and, in other cases, vision injuries claims that now form the backbone of ongoing litigation
PMID: 37 MayoKEMillerLJBatailleDDalleSGkeBThorensBet al
Furthermore, obesity accounts for 44% of the diabetes burden, 23% of the ischemic heart disease burden and up to 41% of cancer burden globally [2]
Lastly, patients with heart failure (HF), composite cardiovascular events (i.e., unstable angina, ischemic heart disease, myocardial infarction, coronary stenting, percutaneous coronary intervention (PCI), coronary artery bypass), and clinically significant portal hypertension events (i.e., esophageal varices with and without bleeding, ascites, hepatic failure, hepatorenal syndrome, portal hypertension, liver transplant status, fibrosis, sclerosis and cirrhosis of the liver, hepatic encephalopathy, jaundice) were excluded if they occurred before inclusion to the cohort or prior to the index event